The efficacy of ado-trastuzumab emtansine in patients with ERBB2-aberrant non-small cell lung cancer: a systematic review

BACKGROUND: ERBB2 aberrations are oncogenic alterations in lung cancer. However, the reported therapeutic efficacy of ado-trastuzumab emtansine (T-DM1) varied. We therefore evaluated the efficacy and safety of T-DM1 in treating different types of ERBB2 aberrations. METHODS: We conducted a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiu, Jin, Rui, Lou, Lingyun, Zhao, Jie, Xia, Lexin, Zhao, Jing, Li, Wen, Xu, Zhihao, Xia, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798601/
https://www.ncbi.nlm.nih.gov/pubmed/35117816
http://dx.doi.org/10.21037/tcr-19-2759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798601/
https://www.ncbi.nlm.nih.gov/pubmed/35117816
http://dx.doi.org/10.21037/tcr-19-2759

Ejemplares similares